<!DOCTYPE html>
<html lang="ru">

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    <!-- <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.1.3/css/bootstrap.min.css"
        integrity="sha384-MCw98/SFnGE8fJT3GXwEOngsV7Zt27NXFoaoApmYm81iuXoPkFOJwJ8ERdknLPMO" crossorigin="anonymous"> -->
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.5.0/css/all.css">
    <link href="https://fonts.googleapis.com/css?family=Open+Sans" rel="stylesheet">
    <!-- <link rel="stylesheet" href="css/owl.carousel.min.css"> -->
    <!-- <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.5.0/css/all.css"> -->
    <link href="https://fonts.googleapis.com/css?family=Germania+One" rel="stylesheet">
    <title>Tegretol</title>

</head>

<body>


    <div class="container cont728x90">
        <div class="Vector_Smart_Object">
            <img src="img/Vector_Smart_Object222_copy_6.png" alt="Vector_Smart_Object222_copy_6">
        </div>
        <div class="GettyImages">
            <img src="img/GettyImages-878493416.png" alt="">
        </div>
        <h2 class="Your_epilepsy">Your epilepsy patients could achieve seizure freedom with
            <br>Tegretol<sup>&#174;1</sup>
            or Trileptal<sup>&#174;2</sup> at any age</h2>
        <div class="white_bg">
            <div class="Novartis_Logo"><img src="img/Novartis_Logo.png" alt="Novartis_Logo"></div>
            <a href="#">Rollover to learn more</a>
            <a href="#" class="p_Global_Basic">Global Basic Succinct Statement</a>
            <p>&#169; 2019 Novartis</p>
            <p>10/19</p>
            <p>GLEM/TRILEPTAL/0023</p>

        </div>
        <div class="two_images">
            <img src="img/Tegretol.png" alt="Tegretol">
            <img src="img/Trileptal.png" alt="Trileptal">
        </div>
        <p class="p_ul">
            1. Glauser T, <i>et al. Epilepsia</i> 2013; 54(3): 551-63. doi: 10.1111/epi.12074;<br>
            2. Kanner AM, <i>et al. Neurology</i> 2018; 91(2): 74-81.
        </p>


    </div>

    <div class="container big_banner728x540">
        <img class="Vector_Smart_Object22" src="img/Vector_Smart_Object22_copy_5.png"
            alt="Vector_Smart_Object22_copy_5">
        <div class="family">
            <img src="img/GettyImages-8784934162.png" alt="GettyImages">
        </div>

        <div class="big_banner728x540_text">
            <h2 class="Did_you_know">Did you know that seizure worry is the most important concern for patients with
                epilepsy?<sup>1</sup></h2>

            <div class="nuwly_percent">
                <div class="nuwly_percent_p1">
                    <h1>72.2%</h1>
                    <p class='n_39'>(n=39/54)</p>
                    <p>of newly-diagnosed epilepsy patients (â‰¥17 years) achieved 1-year seizure freedom
                        with<br><span>Trileptal<sup>&#174;</sup> (oxcarbazepine) </span>monotherapy<sup>*2</sup></p>
                </div>
                <div class="nuwly_percent_p1">
                    <h1>61%</h1>
                    <p class='n_39'>(n=49/81)</p>
                    <p>of newly-diagnosed paediatric patients (5-18 years) achieved seizure freedom at 48 weeks
                        with<span>Trileptal<sup>&#174;</sup> (oxcarbazepine) </span>monotherapy<sup>**3</sup></p>
                </div>
            </div>
            <div class="z_i">
                <h3 class="across">Across 46 randomised clinical trials,</h3>
                <p class="across_p1"><span>Tegretol<sup>&#174;</sup> (carbamazepine)</span> showed superior efficacy
                    compared to many other
                    anti-epileptic drugs in newly-diagnosed paediatric patients with focal epilepsy<sup>4</sup></p>
                <p class="across_p2">
                    <span>Tegretol<sup>&#174;</sup> (carbamazepine)</span> is also a suitable first-line treatment for
                    adults with partial onset seizures<sup>5</sup>
                </p>
            </div>
            <div class="text_ul">
                <p>
                    <b>1. Chen J, <i>et al. Epilepsy Behav</i> 2018; 82: 128-32; 2. Pauletto G and
                        Bergonzi P. <i>Seizure</i> 2006; 15(3): 150-5;<br>
                        3. Guerreiro MM, <i>et al. Epilepsy Res</i> 1997; 27(3): 205-13; 4. Rosati A,
                        <i>et al.
                            Epilepsia</i> 2018; 59(2): 297-314;<br> 5. NICE. Epilepsies: diagnosis and
                        management, Clinical Guideline
                        137.
                    </b>
                </p>
            </div>
        </div>

        <div class="footer">
            <img class='' src="img/Novartis_Logo2.png" alt="Novartis_Logo"><img class='' src="img/Tegretol2.png"
                alt="Tegretol"><img class='' src="img/Trileptal2.png" alt="Trileptal">
            <div class="">
                <a href="#" class="p_Global_Basic">Global Basic Succinct Statement</a>
                <span>10/19</span>
                <span>GLEM/TRILEPTAL/0023</span>
            </div>
        </div>


    </div>

    <link rel="stylesheet" href="css/main.min.css">
    <script src="js/scripts.min.js"></script>

</body>

</html>